BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17009118)

  • 1. Role of matrix metalloproteinase-7 in colorectal adenomas.
    Kirimlioglu H; Kirimlioglu V; Yilmaz S; Sagir V; Coban S; Turkmen E; Hilmioglu F
    Dig Dis Sci; 2006 Nov; 51(11):2068-72. PubMed ID: 17009118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of matrix metalloproteinases in colorectal carcinogenesis.
    Heslin MJ; Yan J; Johnson MR; Weiss H; Diasio RB; Urist MM
    Ann Surg; 2001 Jun; 233(6):786-92. PubMed ID: 11371737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of matrix metalloproteinase-7 in human colorectal adenomas using specified automated cellular image analysis system: a clinicopathological study.
    Qasim BJ; Ali HH; Hussein AG
    Saudi J Gastroenterol; 2013; 19(1):23-7. PubMed ID: 23319034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubular adenomas with minor villous changes show molecular features characteristic of tubulovillous adenomas.
    Ishii T; Notohara K; Umapathy A; Mallitt KA; Chikuba H; Moritani Y; Tanaka N; Rosty C; Matsubara N; Jass J; Leggett B; Whitehall V
    Am J Surg Pathol; 2011 Feb; 35(2):212-20. PubMed ID: 21263241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-13 expression in the progression of colorectal adenoma to carcinoma : Matrix metalloproteinase-13 expression in the colorectal adenoma and carcinoma.
    Foda AA; El-Hawary AK; Abdel-Aziz A
    Tumour Biol; 2014 Jun; 35(6):5653-8. PubMed ID: 24563279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of epidermal growth factor receptor with morphological features of colorectal advanced adenomas: a pilot correlative case series.
    Bansal A; Liu X; McGregor DH; Singh V; Hall S
    Am J Med Sci; 2010 Oct; 340(4):296-300. PubMed ID: 20622650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas.
    Tomita T; Iwata K
    Dis Colon Rectum; 1996 Nov; 39(11):1255-64. PubMed ID: 8918435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.
    Lakis S; Papamitsou T; Panagiotopoulou C; Kotakidou R; Kotoula V
    World J Gastroenterol; 2010 May; 16(20):2476-83. PubMed ID: 20503447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers.
    Murnane MJ; Cai J; Shuja S; McAneny D; Willett JB
    Hum Pathol; 2011 May; 42(5):688-701. PubMed ID: 21237495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.
    Herszényi L; Sipos F; Galamb O; Solymosi N; Hritz I; Miheller P; Berczi L; Molnár B; Tulassay Z
    Pathol Oncol Res; 2008 Mar; 14(1):31-7. PubMed ID: 18347934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component.
    Kakar S; Deng G; Cun L; Sahai V; Kim YS
    Hum Pathol; 2008 Jan; 39(1):30-6. PubMed ID: 17950780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cyclooxygenase expression in human colorectal adenomas.
    Chapple KS; Scott N; Guillou PJ; Coletta PL; Hull MA
    Dis Colon Rectum; 2002 Oct; 45(10):1316-24. PubMed ID: 12394429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
    Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
    Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine kinase in colorectal adenoma.
    Hatada T; Sakanoue Y; Kusunoki M; Yanagi H; Yamamura T; Utsunomiya J
    Acta Oncol; 1993; 32(1):23-8. PubMed ID: 8466759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent activating GNAS mutations in villous adenoma of the colorectum.
    Yamada M; Sekine S; Ogawa R; Taniguchi H; Kushima R; Tsuda H; Kanai Y
    J Pathol; 2012 Sep; 228(1):113-8. PubMed ID: 22374786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional configuration of crypts of different types of colorectal adenomas.
    Araki K; Ogata T
    Scanning Microsc; 1995 Mar; 9(1):149-56; discussion 156-8. PubMed ID: 8553013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal adenomas produce lysozyme.
    Rubio CA
    Anticancer Res; 2003; 23(6D):5165-71. PubMed ID: 14981984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG uptake in colonic villous adenomas.
    Arslan N; Dehdashti F; Siegel BA
    Ann Nucl Med; 2005 Jun; 19(4):331-4. PubMed ID: 16097645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal adenomas: time for reappraisal.
    Rubio CA
    Pathol Res Pract; 2002; 198(9):615-20. PubMed ID: 12440784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarker.
    Williet N; Petcu CA; Rinaldi L; Cottier M; Del Tedesco E; Clavel L; Dumas O; Jarlot C; Bouarioua N; Roblin X; Peoc'h M; Phelip JM
    Oncotarget; 2017 Mar; 8(10):16507-16517. PubMed ID: 28157706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.